P-101A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy. (2nd July 2019) - Parisi, A; Cortellini, A; Roberto, M; Venditti, O; Santini, D; Dell'Aquila, E; Stellato, M; Marchetti, P; Occhipinti, M; Zoratto, F; Mazzuca, F; Tinari, N; et al.